Paclitaxel aids in breast cancer survival, research says

05/27/2008 | Washington Post (tiered subscription model), The

Female patients with early non-metastatic breast cancer who received the drug paclitaxel and underwent standard chemotherapy showed improved disease-free survival in a late-stage trial, Spanish scientists reported. Though the study also found a trend toward enhanced overall survival, it failed to achieve statistical significance. Such a benefit "may become evident with a more protracted follow-up," a study author said.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA